Pharmaceutical compositions containing erythrine mulungu...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/395 (2006.01) A61K 36/48 (2006.01) A61P 25/00 (2006.01) A61P 25/22 (2006.01) C07D 487/00 (2006.01)

Patent

CA 2626700

The present invention provides the use of molecules for cholinergic serotonergic and/or gabaergic system models, revealing pharmaceutical compositions comprising 11-OH-erythravine, erythravine, erythrartine, pharmaceutically acceptable isotherals, salts, byproducts and/or solvates thereof, optionally containing other Erythrine byproducts, for the treatment of anxiety disorders; processes for obtaining said pharmaceutical compositions

L'invention concerne l'utilisation de molécules destinées à des modèles de systèmes cholinergiques, sérotonergiques et/ou gabaergiques; la mise en évidence de compositions pharmaceutiques comprenant 11-OH-érythravine, érythravine, érythrartine, des isothérals pharmaceutiquement acceptables, des sels, des sous-produits et/ou des solvates ceux-ci contenant éventuellement d'autres sous-produits d'érythrine permettant de traiter les troubles de l'anxiété; et des procédés permettant d'obtenir lesdites compositions pharmaceutiques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Pharmaceutical compositions containing erythrine mulungu... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Pharmaceutical compositions containing erythrine mulungu..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pharmaceutical compositions containing erythrine mulungu... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-2014051

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.